De Generic Bio-Tech Private Limited, a active private limited company, was established on 23 May 2011 in Hyderabad, Telangana, India. Engaging in biotechnology within the life sciences sector, it holds CIN: U15122TG2011PTC074610. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.
It upholds a active non-compliant status. Its leadership includes Venigalla Srinivas (Director), Vijay Kumar Pal (Additional Director), Sai Kumar Akella (Director). Past directors included Polugari Madubabu, Nagaraju Shiva Rama Krishnam Raju, Battula Rama Krishna. It holds ₹1.40 Cr open charges and no settled loans. Its latest AGM occurred on 09 August 2018, with the balance sheet filed on 31 March 2018. It is based at H.No : 2-23-B/129/A , Plot No- 129/A Samath Nagar , Near Mnr College, Kukatpa, Lly, Hyderabad, Telangana, 500072.
U15122TG2011PTC074610
074610
23 May 2011
₹2.50 M
₹2.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into De Generic Bio-Tech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venigalla Srinivas | Director | 23 May 2011 | Current |
| Vijay Kumar Pal | Additional Director | 03 Jul 2018 | Current |
| Sai Kumar Akella | Director | 23 May 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Dec 2013 | Past |
| Pramod Abcsdd | Director | 17 Dec 2013 | Past |
| Pramod Abcsdd | Additional Director | 03 Jul 2018 | Past |
| Pramod Abcsdd | Additional Director | 26 Jun 2019 | Past |
| Pramod Abcsdd | Director | 08 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
De Generic Bio-Tech Private Limited, for the financial year ended 2014, experienced significant growth in revenue, with a 135.72% increase. The company also saw a substantial improvement in profitability, with a 47.92% increase in profit. The company's net worth Soared by an impressive increase of 33.98%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, De Generic Bio-Tech had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹14,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Apr 2016 | Others | ₹1.40 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with De Generic Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of De Generic Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped De Generic Bio-Tech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity De Generic Bio-Tech Private Limited last Annual general meeting of members was held on 09 Aug 2018 as per latest MCA records. was completed.
The activity Vijay Kumar Pal was appointed as a Additional Director was appointed as a Additional Director on 03 Jul 2018 & has been associated with this company since 7 years 4 months . was completed.
Progress on De Generic Bio-Tech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad. was documented.
Progress on A charge with Others amounted to Rs. 14.00 M with Charge ID 100033969 was registered on 16 Apr 2016. was documented.
Progress on Venigalla Srinivas was appointed as a Director was appointed as a Director on 23 May 2011 & has been associated with this company since 14 years 6 months . was documented.
Progress on Sai Kumar Akella was appointed as a Director was appointed as a Director on 23 May 2011 & has been associated with this company since 14 years 6 months . was documented.
The CIN of De Generic Bio-Tech Private Limited is U15122TG2011PTC074610.
De Generic Bio-Tech Private Limited is headquartered at H.No : 2-23-B/129/A , Plot No- 129/A Samath Nagar , Near Mnr College, Kukatpa, Lly, Hyderabad, Telangana, 500072.
De Generic Bio-Tech Private Limited was incorporated on 23 May 2011.
The current directors of De Generic Bio-Tech Private Limited are
The primary industry of De Generic Bio-Tech Private Limited is Life Sciences.
De Generic Bio-Tech Private Limited is unlisted.
The authorized capital of De Generic Bio-Tech Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.
The compliance status of De Generic Bio-Tech Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX